3-45975359-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024513.4(FYCO1):​c.289-14T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 1,599,240 control chromosomes in the GnomAD database, including 148,401 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 11782 hom., cov: 32)
Exomes 𝑓: 0.43 ( 136619 hom. )

Consequence

FYCO1
NM_024513.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.51

Publications

17 publications found
Variant links:
Genes affected
FYCO1 (HGNC:14673): (FYVE and coiled-coil domain autophagy adaptor 1) The gene encodes a Rab7 adapter protein that is implicated in the microtubule transport of autophagosomes. The encoded protein contains a RUN domain, a FYVE-type zinc finger domain, and Golgi dynamics (GOLD) domain. The encoded protein plays a role in microtubule plus end-directed transport of autophagic vesicles through interactions with the small GTPase Rab7, phosphatidylinositol-3-phosphate (PI3P), the autophagosome marker LC3, and the kinesin KIF5. Mutations in this gene are associated with inclusion body myositis (IBM) and autosomal recessive congenital cataracts (CATC2). [provided by RefSeq, Aug 2020]
FYCO1 Gene-Disease associations (from GenCC):
  • cataract 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • total early-onset cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-45975359-A-T is Benign according to our data. Variant chr3-45975359-A-T is described in ClinVar as Benign. ClinVar VariationId is 261725.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.656 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FYCO1NM_024513.4 linkc.289-14T>A intron_variant Intron 4 of 17 ENST00000296137.7 NP_078789.2 Q9BQS8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FYCO1ENST00000296137.7 linkc.289-14T>A intron_variant Intron 4 of 17 1 NM_024513.4 ENSP00000296137.2 Q9BQS8-1

Frequencies

GnomAD3 genomes
AF:
0.357
AC:
54302
AN:
151978
Hom.:
11769
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.119
Gnomad AMI
AF:
0.365
Gnomad AMR
AF:
0.517
Gnomad ASJ
AF:
0.389
Gnomad EAS
AF:
0.675
Gnomad SAS
AF:
0.368
Gnomad FIN
AF:
0.474
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.421
Gnomad OTH
AF:
0.368
GnomAD2 exomes
AF:
0.442
AC:
110744
AN:
250712
AF XY:
0.435
show subpopulations
Gnomad AFR exome
AF:
0.112
Gnomad AMR exome
AF:
0.605
Gnomad ASJ exome
AF:
0.390
Gnomad EAS exome
AF:
0.669
Gnomad FIN exome
AF:
0.475
Gnomad NFE exome
AF:
0.424
Gnomad OTH exome
AF:
0.428
GnomAD4 exome
AF:
0.428
AC:
619019
AN:
1447144
Hom.:
136619
Cov.:
27
AF XY:
0.425
AC XY:
306180
AN XY:
720976
show subpopulations
African (AFR)
AF:
0.104
AC:
3457
AN:
33112
American (AMR)
AF:
0.593
AC:
26494
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
0.390
AC:
10158
AN:
26054
East Asian (EAS)
AF:
0.642
AC:
25443
AN:
39632
South Asian (SAS)
AF:
0.360
AC:
30902
AN:
85950
European-Finnish (FIN)
AF:
0.463
AC:
24672
AN:
53288
Middle Eastern (MID)
AF:
0.346
AC:
1990
AN:
5752
European-Non Finnish (NFE)
AF:
0.428
AC:
470339
AN:
1098820
Other (OTH)
AF:
0.427
AC:
25564
AN:
59892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
16650
33300
49950
66600
83250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14334
28668
43002
57336
71670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.357
AC:
54329
AN:
152096
Hom.:
11782
Cov.:
32
AF XY:
0.364
AC XY:
27086
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.119
AC:
4956
AN:
41512
American (AMR)
AF:
0.517
AC:
7905
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.389
AC:
1349
AN:
3466
East Asian (EAS)
AF:
0.675
AC:
3481
AN:
5160
South Asian (SAS)
AF:
0.367
AC:
1772
AN:
4826
European-Finnish (FIN)
AF:
0.474
AC:
5007
AN:
10556
Middle Eastern (MID)
AF:
0.299
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
0.422
AC:
28647
AN:
67964
Other (OTH)
AF:
0.374
AC:
792
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1612
3225
4837
6450
8062
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
512
1024
1536
2048
2560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.384
Hom.:
2241
Bravo
AF:
0.350
Asia WGS
AF:
0.512
AC:
1781
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cataract 18 Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
11
DANN
Benign
0.74
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs751552; hg19: chr3-46016851; COSMIC: COSV56114702; API